News Jun 12, 2023 Lonza boosts next-generation anticancer drugs with CHF 97 million investment in Visp Pharma giant Lonza is enhancing its capabilities in the development of novel cancer treatments through an investment of over CHF 97 million in Vi...
News Jun 06, 2023 Novocure to donate 3 million US dollars to cancer research Novocure, a biotechnology firm specializing in the field of oncology, has pledged support of 1 million US dollars per year for a period of three ...
Global Opportunities Jun 01, 2023 Colombia: Biotech business opportunities Colombia’s aim is to be recognized by 2032, as a leader in the development, production, marketing and export of high value-added products derived...
News Jun 01, 2023 InterAx Biotech helps Sosei Heptares with drug discovery The British pharmaceutical company Sosei Heptares has agreed a partnership with InterAx Biotech AG. It plans to use the platform of the Aargau-ba...
News May 26, 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
Success stories May 25, 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
Success stories May 25, 2023 CSL Behring: “The deciding factors were time to market and the proven track record of the Bern site.” CSL Behring For over a century, CSL Behring (CSLB) has kept its founding promise to help patients suffering from rare and serious diseases. It specializes in...
Success stories May 25, 2023 Yokogawa Innovation Switzerland: How microalgae open up new possibilities for food and medicine. Yokogawa Electric Corporation Microalgae open up new possibilities for food and medicine. From its base in Switzerland, the mission of YIS is to find promising biotechnology f...
News May 24, 2023 Latest research shows 20% of European biotechs now headquartered in Switzerland Press release New research conducted by IQVIA and recently published in the 2023 Swiss Biotech Report shows that 20% of European biotech companies are now head...
News May 24, 2023 VectivBio sold for approximately 1 billion dollars The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine,...
News May 23, 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
News May 17, 2023 Geneva start-ups Fluosphera, Kylys Aesthetics and Consulto receive FIF support The Fondation Genevoise pour l’Innovation Technologique (Fongit) has announced the latest recipients of the Fongit Innovation Fund (FIF) support....
News May 17, 2023 CSL Behring expands R&D presence with new office at Biopôle Global biotech leader CSL Behring is set to strengthen its ties with Western Switzerland’s life sciences community by opening a research and deve...
News May 16, 2023 NewBiologix pioneers breakthrough gene therapies with USD 50 million investment NewBiologix, a biotechnology start-up founded by industry veterans Igor Fisch and Nicolas Mermod, has announced a USD 50 million Series A funding...
News May 09, 2023 Siegfried acquires majority in DiNAMIQS Siegfried has acquired a stake of 95 percent in DiNAMIQS. The global life sciences firm is planning to bring the development and production platf...
News Apr 27, 2023 Swiss biotech achieves record sales again in 2022 The Swiss biotech sector achieved record figures for sales, investments and employment in 2022, according to the latest Swiss Biotech Report. The...
News Apr 26, 2023 Western Switzerland’s biotech sector flourishes amidst global challenges Western Switzerland's biotech industry continues to thrive, displaying resilience amidst global challenges. The region's unique ecosystem fosters...
News Mar 29, 2023 Alithea Genomics secures CHF 500,000 to boost RNA sequencing technology Alithea Genomics has secured a CHF 500,000 Tech Growth loan from the FIT to launch two new products and expand its RNA sequencing technology port...